|
Market Closed -
NSE India S.E.
07:05:07 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 1,423.50 INR | +0.25% |
|
-0.61% | -5.81% |
| 08-25 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
| 08-13 | Cipla Announces Appointment of Runa Akhtar to Marketing Head, Cipla Urology | CI |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 3B | 13.77% | 16.59% | 11.82% | 9.71% | -1.48x | |
| 6.23B | 19.64% | 23.18% | 14.74% | 11.43% | -1.73x | |
| 15.75B | 14.71% | 19.42% | 12.6% | 11.79% | -0.55x | |
| 2.9B | 18.56% | 26.03% | 19.74% | 11.25% | 1.22x | |
| 2.4B | 19.76% | 22.79% | 17.5% | 13.7% | -0.62x | |
| 2.84B | 25.01% | 31.52% | 17.22% | - | -0.6x | |
| 1.81B | 8.02% | 23.55% | 14.07% | - | -0.13x | |
| 3.24B | 13.53% | 17.88% | 8.5% | 8.54% | -0.89x | |
| 622M | 14.97% | 15.69% | 7.44% | - | - | |
| 582M | 19.37% | 22.4% | 25% | 18.91% | -0.32x | |
| 2.44B | -2.5% | 3.31% | 5.52% | 3.41% | 3.1x | |
| 1.12B | 16.84% | 20.12% | 16.25% | 10.21% | -1.26x | |
| 819M | 21.72% | 22.62% | 24.31% | 15.24% | 0.23x | |
| 400M | 30.91% | 31.64% | 28.92% | 24.3% | -0.68x | |
| 227M | 27.68% | 29.99% | 20.76% | - | - | |
| Average | 2.96B | 17.46% | 21.78% | 16.29% | 12.59% | -0.29x | |
| Weighted average by Cap. | 6.52B | 16.99% | 21.55% | 14.67% | 11.65% | -0.73x |
- Stock Market
- Stocks
- CIPLA Stock
- Sector Cipla Limited
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
